University of California, San Francisco
Center for BioEntrepreneurship

Coaches on Campus

Contact Us I Home I

CBE Presents… Coaches on Campus

Program Overview

(Printer Friendly Version)

The Center for BioEntrepreneurship is pleased to launch a novel program providing free coaching services by life science industry experts to facilitate new product development.

DO YOU…

  • have an idea for an innovative technology? 
  • want to prepare a winning business plan?
  • need to conduct a market assessment?
  • dream of starting your own company?

Then, here is an opportunity for you to obtain feedback from industry coaches as you proceed down the complex pathway from conception to commercialization. Experts will meet with you individually, evaluate your proposed ideas, and answer your questions.

You can practice pitching your idea, discuss the commercial potential of your technology, inquire about the fundraising process, and assess how your idea might be received. All discussions will be treated as confidential.

Take advantage of this unique program and reserve a time slot for your free consultation with an experienced venture capitalist, attorney, or bioengineer. This unique service is limited to UCSF students, faculty, staff, and alumni.

Submit a brief abstract of your innovation, supporting data, & commercial potential to cbe@ucsf.edu by November 2, 2007 (deadline extended to Nobember 5th)

Select a 30-minute time slot during office hours for consultation

Office hours: Wednesday, November 7, 2007, 3:00-6:00pm, UCSF Mission Bay Campus

VC Hours

Legal Hours

Bioengineering Hours

3:00 – 3:30

3:30 – 4:00

4:00 – 4:30

4:30 – 5:00

5:00 – 5:30

5:30 – 6:00

UCSF Sponsors:

The Center for BioEntrepreneurship (CBE) educates aspiring entrepreneurs through unique programs and facilitates interactions with industry experts.

The California Institute for Quantitative Biosciences (QB3) addresses biological problems through multidisciplinary scientific initiatives and global partnerships.

MEET THE COACHES AND COMPANIES:

VC HOURS

Advanced Technology Ventures (ATV) works closely with entrepreneurial teams in several technology markets, including medical devices, biopharmaceuticals, diagnostics, clean tech and various information technology sectors, to turn emerging-growth business ventures into market leaders. Founded in 1979, ATV is a bi-coastal venture capital firm with more than $1.4 billion in capital under management. With more than 27 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises. www.atvcapital.com .

Tom Rodgers, Principal, Advanced Technology Ventures (ATV), focuses on new investments in the medical device and life sciences sectors. Prior to joining ATV in 2004, Tom had 12 years of operating experience in the healthcare industry most recently serving as Vice President of Corporate Strategy and Business Development at McKesson Corporation, a Fortune 15 company that leads the healthcare IT and pharmaceutical services industries. Previously, Tom managed sales and strategic efforts for FitLinxx, a venture-backed startup that pioneered and continues to lead the fitness and rehab intelligence technology market. His management background also includes marketing roles at biotechnology leader Genentech and consulting at The Wilkerson Group where he focused on medical devices and diagnostics.  Tom earned an MBA from the Wharton School and a BA in the History of Medicine and Technology from the University of Pennsylvania. He currently sits on the boards of Aperio, Gynesonics, Helixis, and Juniper Medical on behalf of ATV.

Amy Belt, Senior Associate, Advanced Technology Ventures (ATV) is in the firm's healthcare practice, where she focuses on investments in the medical device sector.  Prior to joining ATV, Amy led Global Marketing initiatives at Abbott Vascular (formerly Guidant Corporation) including product launches in the US, Europe and Asia. Most recently, she was a Group Manager of the Drug Eluting Stent program where she managed a team of product managers to launch the company's drug eluting stent internationally, marking the company's entrance into the $5 billion worldwide DES market. While at Abbott, Amy also held positions marketing brachytherapy and angioplasty products. Prior to Abbott, Amy held a marketing position at Bristol-Myers Squibb working on various cardiovascular and neuroscience products. She was previously a management consultant in the healthcare practice at CSC (formerly APM) where she worked with hospitals, physicians and payers on strategic, clinical and operations initiatives.  Amy holds an M.B.A from the Walter Haas School of Business at the University of California at Berkeley and a B.A. from Yale University .

Alta Partners is a San Francisco-based venture capital firm focused on life sciences investing. Founded in 1996, the firm currently manages $2 billion in committed capital through eight venture fund programs. Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 110 companies in the sector to date.
www.altapartners.com

Robert Alexander, Ph.D., joined Alta in 2005 to focus on life sciences investments and currently serves on the board of directors of SARcode Corporation.  Prior to Alta, Robert was a Principal in MPM Capital's BioEquities fund where he sourced opportunities and led due diligence efforts for both public and private investments.  Robert joined MPM from Genentech where he worked in the Business Development group.  At Genentech, his responsibilities included sourcing and screening product opportunities based on scientific merit and strategic fit, leading diligence teams and negotiating terms and definitive agreements. Prior to joining Genentech, Robert was a post-doctoral fellow at Stanford University in the department of Pathology.  He holds a Ph.D. in Immunology from the University of North Carolina and a Bachelor of Arts degree in Zoology from Miami University of Ohio.

LEGAL HOURS

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.,  is a versatile law firm providing diverse legal services and resources. The firm is recognized for entrepreneurial zeal and leadership in the areas of biotechnology, life sciences, health care, communications, information technology, and high technology. Clients include major public corporations, privately held and family businesses, entrepreneurs, start-ups and emerging growth companies, investors, underwriters, directors and officers, research scientists, medical and academic institutions, public agencies and industry associations.
http://www.mintz.com

Jason Altieri is a member in the Palo Alto office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, practicing in the Business and Finance and Technology & Licensing Section. Jason has represented both public and private companies in the technology, medical device, education, and retail sectors. He has experience in a wide variety of transactions, ranging from venture capital financings, public equity and 144A transactions to mergers and acquisition transactions. Prior to joining Mintz Levin, Jason was a partner at a San Francisco area law firm and prior to that an associate with a premier Silicon Valley firm. Jason is admitted to practice law in California. He obtained a B.A. in Economics, with honors, from the University of California, Davis and an M.A. in International Economics and Public Policy from the University of California, San Diego. Jason was awarded his J.D., magna cum laude, from the University of San Francisco School of Law.

Matt Kirmayer is a member in the Palo Alto office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, practicing in the Business and Finance Section. His practice is focused on the representation of emerging technology companies, venture capital and private equity funds and institutional investors. Matt represents clients in many industries, including nanotechnology, life sciences and medical devices, as well as multimedia, wireless technologies, networking, internet infrastructure and security, Prior to joining Mintz Levin, he was a partner at a San Francisco area law firm. Matt began his career in New York City handling securities offerings and merger and acquisition transactions. Matt is admitted to practice law in California and New York. He was awarded his B.A. from the State University of New York at Albany and his J.D. from Rutgers University. Matt obtained his LL.M. from New York University School of Law.

BIOENGINEERING HOURS

Aubrey Group, Inc., is a medical product development, contract engineering and manufacturing firm specializing in the design and manufacturing of electronic and electromechanical devices for medical use. Services include medical system design, electronics and computer design, RF system and circuit design, software development, industrial design, mechanical engineering, rapid prototyping, testing, validation and verification, documentation, and turnkey manufacturing. The Group can serve as an adjunct to existing programs within companies or as a complete service provider.
http://www.aubreygroup.com/

Gil Peterson, Aubrey Group Regional Director for Northern California, works closely with many start-up companies to develop new technologies. Gil was most recently President of his own consulting firm, MDpower, where he served as an interim executive for a number of early-stage health care companies. He has also held senior functional and general management positions with Hewlett-Packard, Perkin-Elmer and Varian, managing business units that twice won Industrial Research Magazine Awards for the 100 Most Significant Technical Products of the Year.

Joseph Heanue is President of Triple Ring Technologies, a research and development firm that provides virtual development teams in the medical device and life science areas. He recently led a team responsible for product development and commercial release of a catheter-based x-ray radiation-therapy device for Xoft, Inc.  He previously served as Vice President of Engineering at NexRay and at Signature BioScience. At NexRay, Joe led the development of a low-dose x-ray imaging system for interventional cardiology. At Signature, he headed a group that delivered prototype RF and microwave spectroscopy instruments to a major instrument partner. Joe holds patents in spectroscopy and imaging, including a system-architecture patent licensed to a major medical equipment manufacturer.  He received a BS in Physics from the Massachusetts Institute of Technology and a Ph.D. in Electrical Engineering and Computer Science from the University of California at Berkeley . Joe was a postdoctoral researcher at Xerox PARC , and he completed the Stanford University Executive Program for Growing Companies.

Triple Ring Technologies is a provider of advanced research and development services located in Palo Alto , California . Founded in 2005, the company has a passion for finding simple solutions to complex problems spanning, science, technology, and business. The Triple Ring Team includes senior professionals with extensive experience in medical device and life science technologies. Triple Ring brings a highly collaborative approach to the early stage development process. Clients include investors, entrepreneurs, and established companies in the medical device, life sciences, industrial instrumentation, optics, and digital imaging fields.

www.tripleringtech.com

For more information on CBE events contact Gail Schechter or
Giselle F. Martin

Comments (0)